Cargando…
MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells
BCR-ABL-independent resistance against tyrosine kinase inhibitor is an emerging problem in therapy of chronic myeloid leukemia. Such drug resistance can be linked to dysregulation of ATP-binding cassette (ABC)-transporters leading to increased tyrosine kinase inhibitor efflux, potentially caused by...
Autores principales: | Kaehler, Meike, Ruemenapp, Johanna, Gonnermann, Daniel, Nagel, Inga, Bruhn, Oliver, Haenisch, Sierk, Ammerpohl, Ole, Wesch, Daniela, Cascorbi, Ingolf, Bruckmueller, Henrike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696160/ https://www.ncbi.nlm.nih.gov/pubmed/29190894 http://dx.doi.org/10.18632/oncotarget.21272 |
Ejemplares similares
-
Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistance
por: Klümper, Theresa, et al.
Publicado: (2020) -
Genome-wide expression and methylation analyses reveal aberrant cell adhesion signaling in tyrosine kinase inhibitor-resistant CML cells
por: Kaehler, Meike, et al.
Publicado: (2022) -
Germline variants in cancer therapy
por: Kaehler, Meike, et al.
Publicado: (2019) -
Pharmacogenomics of Impaired Tyrosine Kinase Inhibitor Response: Lessons Learned From Chronic Myelogenous Leukemia
por: Kaehler, Meike, et al.
Publicado: (2021) -
Implications of genetic variation of common Drug Metabolizing Enzymes and ABC Transporters among the Pakistani Population
por: Afsar, Nasir Ali, et al.
Publicado: (2019)